Antifungal Potential of Moringa Olifera Against Otomycosis
Status:
Enrolling by invitation
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
patients with Otomycosis were recognized by an ENT specialist. 20 patients were distributed
randomly into two groups. The first group will be treated with Nystatin ear drops twice
daily. The second group will be treated with Moringa ear drops. patients will be examined
endoscopically by the ENT specialist. patient's swabs will be isolated and analyzed by ELISA.